© 2021 MJH Life Sciences and Gene Therapy Live. All rights reserved.
© 2021 MJH Life Sciences™ and Gene Therapy Live. All rights reserved.
LogicBio's Mariana Nacht, PhD, shares details of the company's novel capsid discovery platform and gene editing technology.
The news comes after CRISPR’s favorable data readouts in its sickle cell and beta thalassemia studies.
Cynata Therapeutics' Ross Macdonald, PhD, discusses the company's pipeline and clinical-phase trials.